C-Ray Therapeutics is a China-based global CRDMO dedicated to the development and manufacturing of innovative radiopharmaceuticals. The company operates a 10,000 sqm automated, intelligent, and digital Grade A production site with 13 high-standard radiopharmaceutical production lines, and has completed a Series A+ financing round exceeding $100 million.
Radiopharmaceutical development and manufacturing, CRDMO services, preclinical research (AAALAC accredited)
1 site worldwide
Involvement in 3 clinical trials
No reviews available yet.
No documents available.